FDA Inspection
Organon Pharma (UK) Ltd.Organon Pharma (UK) Ltd. – FDA Inspection, Mar 22, 2013
Record Details
This FDA Inspection record concerns Organon Pharma (UK) Ltd., with an inspection on March 22, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Organon Pharma (UK) Ltd.
- Inspection Date
- March 22, 2013
- Product Type
- Drugs
View Company Profile
ID · 06f9c3ba-b3ce-4612-9424-1d98dff0faef
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 826684
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Organon Pharma (UK) Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 13, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Organon Pharma (UK) Ltd.
- FDA Inspection 1273172 - 2025-06-13
- FDA Inspection 1093308 - 2018-06-14
- FDA Inspection 916040 - 2015-02-06
- FDA Inspection 651971 - 2010-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.